drugset / Trial / NCT03547778
Misoprostol in Office Hysteroscopy and Endometrial Biopsy
RandomizedParallel-groupDouble-blindPrevention
Summary
We hypothesize that use of vaginal misoprostol will help in reducing the pain scores when used prior to concurrent office hysteroscopy and endometrial biopsy in a particular subgroup of women who are anticipated to require cervical dilatation.
Timeline
- Start
- 2018-09-01
- Primary completion
- 2019-12-31
- Completion
- 2020-03-25
Publications
- Background Cicinelli E, Didonna T, Ambrosi G, Schonauer LM, Fiore G, Matteo MG. Topical anaesthesia for diagnostic hysteroscopy and endometrial biopsy in postmenopausal women: a randomised placebo-controlled double-blind study. Br J Obstet Gynaecol. 1997 Mar;104(3):316-9. doi: 10.1111/j.1471-0528.1997.tb11460.x.
- Background Urman RD, Punwani N, Bombaugh M, Shapiro FE. Safety considerations for office-based obstetric and gynecologic procedures. Rev Obstet Gynecol. 2013;6(1):e8-e14.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 50 ug | Intravenous |
Indications
No indication recorded.